New York Prescription Saver Card

By: Ebey P. Soman

https://nyprescriptionsaver.fhsc.com/asp/partners.asp

New York Prescription Saver is a pharmacy discount program sponsored by New York State designed to help eligible New York State residents with no insurance to pay for their medications. To be eligible, you must be a resident of New York State; do not have Medicaid; either age 50 and below 65 years old or be disabled and getting SSDI or SSI payments; and have an annual household income of less than $35,000 for singles and $50,000 for married couples. Participating pharmacies agree to provide medications at a discounted rate as arranged by payment contracts signed with the program. This may help patients with no insurance pay for their medications and enabling them to stay adherent to their therapy regiments. So on behalf of all the patients, I would like to thank all the participating pharmacies for thinking of the patients first and bringing a humanistic approach to community pharmacy. Below are some organizations that participate in the program, you may visit the program website to view a complete list of pharmacies near you.

eMAR

Recent Posts

Oxidative Stress and Its Impact on Vitiligo

By: Zurriya Faran, PharmD Candidate c/o 2031 The visible loss of skin pigmentation often indicates…

2 months ago

Thiamine Metabolic Dysfunction Syndrome: Overview, importance, MOA, and treatment

By: Archana Murugan, PharmD candidate c/o 2029 Overview             Thiamine metabolic dysfunction syndrome (TMDS) refers…

2 months ago

Updated Guidelines for the Treatment of Multidrug and Rifampin-Resistant TB and Promising New Anti-TB Drugs in Phase 2/3 Trials

By: Kevin Lee, PharmD Candidate c/o 2028, Angela Yin, PharmD Candidate c/o 2028             The…

2 months ago

Sixth Year Perspective: Interview with Ariella Zadrima, PharmD Candidate, c/o 2026

By: Aymon Choudhury, PharmD Candidate c/o 2027 APPE questions: How did your APPE rotations shape…

2 months ago

Foundayo: The New Drug in the GLP-1 market

By: Sariah Grant, PharmD Candidate c/o 2027             The rise of glucagon-like peptide -1 receptor…

2 months ago

Should All Drugs be OTC? Risks and Consequences of the FDA Commissioner Statement

By: Amanda Kastel, PharmD Candidate c/o 2027 In February 2026, FDA Commissioner Marty Makary stated…

2 months ago